Stryker Cash And Equivalents from 2010 to 2024

SYK Stock  USD 357.87  0.84  0.23%   
Stryker Cash And Equivalents yearly trend continues to be quite stable with very little volatility. Cash And Equivalents may rise above about 2.5 B this year. From the period between 2010 and 2024, Stryker, Cash And Equivalents regression line of its data series had standard deviation of  680,535,876 and standard deviation of  680,535,876. View All Fundamentals
 
Cash And Equivalents  
First Reported
2010-12-31
Previous Quarter
1.7 B
Current Value
2.5 B
Quarterly Volatility
680.5 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Stryker financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Stryker main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 B, Interest Expense of 373.8 M or Total Revenue of 21.5 B, as well as many exotic indicators such as Short Term Coverage Ratios of 1.68, Price Earnings Ratio of 48.53 or Price To Sales Ratio of 2.98. Stryker financial statements analysis is a perfect complement when working with Stryker Valuation or Volatility modules.
  
This module can also supplement Stryker's financial leverage analysis and stock options assessment as well as various Stryker Technical models . Check out the analysis of Stryker Correlation against competitors.
For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.

Latest Stryker's Cash And Equivalents Growth Pattern

Below is the plot of the Cash And Equivalents of Stryker over the last few years. It is Stryker's Cash And Equivalents historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Stryker's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 1.84 B10 Years Trend
Slightly volatile
   Cash And Equivalents   
       Timeline  

Stryker Cash And Equivalents Regression Statistics

Arithmetic Mean3,037,302,857
Geometric Mean2,955,591,177
Coefficient Of Variation22.41
Mean Deviation510,569,905
Median3,316,000,000
Standard Deviation680,535,876
Sample Variance463129.1T
Range2.7B
R-Value(0.55)
Mean Square Error346497.2T
R-Squared0.31
Significance0.03
Slope(84,077,857)
Total Sum of Squares6483807.1T

Stryker Cash And Equivalents History

20242.5 B
20231.7 B
20221.8 B
20212.9 B
20202.9 B
20194.3 B
20183.6 B

About Stryker Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Stryker income statement, its balance sheet, and the statement of cash flows. Stryker investors use historical funamental indicators, such as Stryker's Cash And Equivalents, to determine how well the company is positioned to perform in the future. Although Stryker investors may use each financial statement separately, they are all related. The changes in Stryker's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Stryker's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Stryker Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Stryker. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Cash And Equivalents1.7 B2.5 B

Currently Active Assets on Macroaxis

When determining whether Stryker is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Stryker Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Stryker Stock. Highlighted below are key reports to facilitate an investment decision about Stryker Stock:
Check out the analysis of Stryker Correlation against competitors.
For more information on how to buy Stryker Stock please use our How to buy in Stryker Stock guide.
You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for Stryker Stock analysis

When running Stryker's price analysis, check to measure Stryker's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Stryker is operating at the current time. Most of Stryker's value examination focuses on studying past and present price action to predict the probability of Stryker's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Stryker's price. Additionally, you may evaluate how the addition of Stryker to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Is Stryker's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Stryker. If investors know Stryker will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Stryker listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.027
Dividend Share
3.05
Earnings Share
8.25
Revenue Per Share
53.999
Quarterly Revenue Growth
0.118
The market value of Stryker is measured differently than its book value, which is the value of Stryker that is recorded on the company's balance sheet. Investors also form their own opinion of Stryker's value that differs from its market value or its book value, called intrinsic value, which is Stryker's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Stryker's market value can be influenced by many factors that don't directly affect Stryker's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Stryker's value and its price as these two are different measures arrived at by different means. Investors typically determine if Stryker is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Stryker's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.